Device Trial Radar · NCT02372058
Transcutaneous Bilirubinometry in Neonates With Bilicare System
Last checked: Nov 20, 2026Latest source record: Sep 11, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Gerium MedicalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 26, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Screening
- Who can join
- All sexes, from 6 hours
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of this study is to define the performance evaluation of BiliCare TcB device to the "gold standard" bilirubin tests.
Conditions
- We Will Focus on Assessing the Clinical Performance of the BiliCare Device
Interventions
BiliCareDevice
Three non invasive measurements of TcB: Two measurements with the BiliCare device and one measurement with a competitive FDA approved device
Primary outcomes
What the sponsor says the trial is designed to measure.
- BiliCare TcB Result Compared to TSB ResultTime frame: 30 minutes within taking the blood draw for TSB (either before or after the blood draw)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Einstein Medical Center
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.